ARTICLE | Company News
Creative BioMolecules other research news
October 12, 1998 7:00 AM UTC
CBMI received a $100,000 Phase I SBIR grant from the National Institute of Neurological Disorders and Stroke to fund research with OP-1 and other neurotrophic proteins to restore dopaminergic neurons ...